Back

What is the role of genetic testing?

16 April 2023 (16:45 - 17:00)
Organised by:
Congress Presentation Part of: Channelopathies: current approaches to diagnosis and therapeutics Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Christopher Semsarian

University of Sydney, Sydney (Australia)

3 More presentations in this session

Presentation thumbnail
CPVT: surgery before ICD?
Doctor C. Van Der Werf (Amsterdam, NL)
Slides
Presentation thumbnail
LQTS: genotype guided management and genotype-specific therapy
Associate Professor L. Crotti (Milan, IT)
Slides
Presentation thumbnail
Brugada and early repolarisation syndromes: when to ablate
Professor M. Haissaguerre (Pessac, FR)
Slides

Access the full session

Session thumbnail
Channelopathies: current approaches to diagnosis and therapeutics

The Event

Event poster

EHRA 2023

16 April 2023 16:45 CET
You may be interested in
thumbnail
Congress Presentation
Impact of genetic testing on the management in patients with idiopathic dilated cardiomyopathy
30 June 2021
thumbnail
Webinar
Polygenic risk scores: what is their value for risk prediction and potential for clinical utility?
22 March 2022
thumbnail
Webinar
Exercise testing in cardiovascular patients
9 February 2022
thumbnail
Congress Presentation
Diagnosis of chronic obstructive coronary artery disease: is non-invasive testing the suitable gatekeeper for coronary angiography?
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources